← All indications
Coronary Artery Bypass
Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.
Subtype terms (2)
More specific conditions that are subtypes of Coronary Artery Bypass in the MeSH hierarchy.
Drugs by status
Phase 4 trials (34)
- ringer's lactate
- propofol
- nitroglycerin
- ketamine
- diltiazem
- empagliflozin
- isoflurane
- sevoflurane
- insulin human
- etomidate
- atorvastatin
- colchicine
- ticagrelor
- ropivacaine
- levobupivacaine
- acetylsalicylic acid
- sufentanil
- desflurane
- pantoprazole
- tramadol
- dexmedetomidine
- ketoglutarate
- lansoprazole
- clopidogrel
- pregabalin
- vasopressin
- sodium chloride
- triclosan
- bisoprolol
- quinapril
- +4 more
Phase 3 trials (16)
Phase 2 trials (24)
- sodium nitrite
- modimelanotide
- aminolevulinic acid
- avi-5126
- epoetin
- doxycycline
- bq-123
- alanyl-glutaminyl-glycyl-valine
- fospropofol
- liraglutide
- autologous cd133+ stem cells
- mdco-2010
- rimabotulinumtoxinB
- nitric oxide
- roxadustat
- cyclosporine
- sodium sulfide
- angiotensin 1-7
- nicotinamide
- thiamine
- antithrombin iii (human)
- ferrous citrate
- fish oil
- autologous hematopoietic stem cells
Phase 1 trials (1)